Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual dust mite mixture for allergic rhinitis
ChiCTR-IIR-17013839Phase 2Completed
- Sponsor
- Eye and ENT Hospital of Fudan University
- Start
- Sep 2008
- Modality
- Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of dust mite mixture in allergic rhinitis (AR) and allergic asthma (2 arms), sponsored by Eye and ENT Hospital of Fudan University. Primary endpoint: Clinical efficacy and safety. Started Sep 2008; status: completed.
02
Drugs
dust mite mixture
03
Conditions
allergic rhinitis (AR)allergic asthma
Beyond the preview
Go deeper on ChiCTR-IIR-17013839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IIR-17013839.